Craig Whitman, PharmD, BCCCP, FCCM

Craig Whitman, PharmD, BCCCP, FCCM

Craig Whitman, PharmD, BCCCP, FCCM

  • School of Pharmacy

    • Pharmacy Practice

      • Assistant Dean of Academic Affairs

        Programs

        • Doctor of Pharmacy
      • Clinical Professor

        Programs

        • Doctor of Pharmacy
  • Teaching Contributions:
    • PharmD Didactic Teaching: 
      • P234 Pathophysiology and Therapeutics of Cardiopulmonary Disease II
      • P325 Pathophysiology and Therapeutics of Infectious Diseases
      • P347 Pathophysiology and Therapeutics Recitation III
      • P378 Therapeutic Issues in Critical Care
      • P380 Adverse Drug Reactions II: Case Studies
    • PharmD Experiential Teaching: 
      • Advanced Pharmacy Practice Experience – Clinical Inpatient
      • Advanced Pharmacy Practice Experience – Teaching/Administration Elective
    • Post-Graduate Teaching:
      • PGY2 Internal Medicine Resident – Critical Care rotation
    • Other Teaching Roles: 
      • Temple University Health Sciences Center Interprofessional Education Session Facilitator
  • Clinical Practice and Research Overview:

Dr. Whitman is a Board-Certified Critical Care Pharmacist who maintains a clinical practice in the Temple University Hospital Medical/Respiratory Intensive Care Unit. His practice involves optimizing safe and effective medication use in critically ill patients as part of the interprofessional team. Dr. Whitman’s clinical scholarly pursuits focus on the use of drug therapies in sepsis, managing pain, agitation, and delirium. Dr. Whitman also contributes to scholarship of teaching and learning.

  • Key Publications:
    1. Carter C, Bushwitz J, Gowan M, Pope H, Human T, Gibson G, Owen E, Hampton N, Whitman C. Clinical Experience With Pharmacological Venous Thromboembolism Prophylaxis in the Underweight and Critically Ill. Ann Pharmacother. 2016;50(10):832-9
    2. Whitman CB, Ablordeppey E, Taylor B. Levodopa Withdrawal Presenting as Fever in a Critically Ill Patient Receiving Concomitant Enteral Nutrition. J Pharm Pract. 2016;29(6):574-578
    3. Siemianowski LA, Rosenheck JP, Whitman CB. Nalbuphine-induced psychosis treated with naloxone. Am J Health Syst Pharm. 2014;71(9):717-2
  • Leadership and Service:
    • Temple University School of Pharmacy
      • Assistant Dean of Academic Affairs
      • Member, Executive Committee
      • Member, ex-officio, Curriculum and Assessment Committee
      • Member, ex-officio, Teaching and Evaluation Committee
      • Co-chair, Accreditation Council for Pharmaceutical Education Self-Study (2024)
    • Society of Critical Care Medicine
      • Member, Clinical Pharmacy and Pharmacology Section Program Committee

 

Read the bio.